Receptor signaling, transcriptional, and metabolic regulation of T cell exhaustion

Mumtaz Y Balkhi1,2,3

  • 1Department of Molecular & Biomedical Sciences, University of Maine, Orono, ME, USA.

Oncoimmunology
|May 5, 2020
PubMed

Insights

T cell exhaustion impairs anti-cancer and anti-viral responses. Understanding transcription factor dynamics in T cell exhaustion is key to developing novel cancer immunotherapies.

Area of Science:

  • Immunology
  • Cancer Biology
  • Virology

Background:

  • T cell exhaustion critically impairs effector responses in metastatic cancers and chronic infections.
  • Checkpoint Receptor Blockade (CRB) therapies have shown success in reversing T cell exhaustion in human cancers.
  • Current understanding of T cell exhaustion mechanisms is largely derived from murine models of chronic viral infections.

Purpose of the Study:

  • To review the T cell exhaustion differentiation pathway in both cancer and chronic viral infection contexts.
  • To explore the role of transcription factor expression dynamics in T cell exhaustion fate and maturation.
  • To summarize key transcription factors involved in T cell exhaustion and map associated signaling pathways.

Main Methods:

  • Literature review focusing on T cell exhaustion mechanisms.
  • Analysis of transcription factor roles in T cell differentiation and exhaustion.
  • Construction of signaling pathway maps for T cell exhaustion.

Main Results:

  • Transcription factor expression dynamics significantly influence T cell exhaustion fate and maturation.
  • Key transcription factors play critical roles in the development and maintenance of T cell exhaustion.
  • Signaling pathway maps illustrate complex regulatory networks in T cell exhaustion.

Conclusions:

  • Elucidating transcription factor roles in T cell exhaustion is crucial for advancing cancer immunotherapy.
  • Insights from chronic viral infections inform strategies against T cell exhaustion in cancer.
  • Targeting specific transcription factors holds promise for novel anti-exhaustion therapies.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.5K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
11.0K